ID
45369
Description
Principal Investigator: Arul M. Chinnaiyan, MD, PhD, University of Michigan, Ann Arbor, MI, USA MeSH: https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000567 Transcriptome sequencing of solitary fibrous tumors / hemangiopericytomas from a variety of anatomic sites revealed recurrent gene fusions between two genes, NAB2 and STAT6. All SFTs examined exhibited an in-frame fusion transcript encoding a fusion protein containing the EGR1 interaction domain of NAB2 with the transcriptional activation domain of STAT6. Functional testing of the fusion alleles confirmed the conversion of the wt NAB2 repressor into a transcriptional activator. A range of individual fusion junctions can be detected by next-generation sequencing acro the sample set, highlighting the suitability of this method in the diagnostic characterization of SFTs. This study indentified the pathognomonic alteration in solitary fibrous tumors and illuminates a pathway towards targeted therapeutics for this cancer.
Lien
Mots-clés
Versions (1)
- 04/11/2022 04/11/2022 - Chiara Middel
Détendeur de droits
Arul M. Chinnaiyan, MD, PhD, University of Michigan, Ann Arbor, MI, USA
Téléchargé le
4 novembre 2022
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
dbGaP phs000567 NAB2-STAT6 Gene Fusions in Solitary Fibrous Tumor by Integrative Sequencing
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, consent group, subject source, subject source ID, and affection status of participants with solitary fibrous tumor / hemangiopericytoma and involved in the "Identification of Recurrent NAB2-STAT6 Gene Fusions in Solitary Fibrous Tumor by Integrative Sequencing" project.
- Subject ID, sample ID, sample source, sample source ID, and sample use variable associated with participants with solitary fibrous tumor / hemangiopericytoma and involved in the "Identification of Recurrent NAB2-STAT6 Gene Fusions in Solitary Fibrous Tumor by Integrative Sequencing" project.
- Subject ID, gender, age, anatomic site of tumor, tumor status [malignant or benign] of participants with solitary fibrous tumor / hemangiopericytoma and involved in the "Identification of Recurrent NAB2-STAT6 Gene Fusions in Solitary Fibrous Tumor by Integrative Sequencing" project.
- Sample ID, body site where sample was collected, analyte type of samples, tumor status, and alias name of samples obtained from healthy participants involved in the "Phase I Clinical Trial Describing the Pharmacogenomics of Aspirin" project.
Similar models
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, consent group, subject source, subject source ID, and affection status of participants with solitary fibrous tumor / hemangiopericytoma and involved in the "Identification of Recurrent NAB2-STAT6 Gene Fusions in Solitary Fibrous Tumor by Integrative Sequencing" project.
- Subject ID, sample ID, sample source, sample source ID, and sample use variable associated with participants with solitary fibrous tumor / hemangiopericytoma and involved in the "Identification of Recurrent NAB2-STAT6 Gene Fusions in Solitary Fibrous Tumor by Integrative Sequencing" project.
- Subject ID, gender, age, anatomic site of tumor, tumor status [malignant or benign] of participants with solitary fibrous tumor / hemangiopericytoma and involved in the "Identification of Recurrent NAB2-STAT6 Gene Fusions in Solitary Fibrous Tumor by Integrative Sequencing" project.
- Sample ID, body site where sample was collected, analyte type of samples, tumor status, and alias name of samples obtained from healthy participants involved in the "Phase I Clinical Trial Describing the Pharmacogenomics of Aspirin" project.
C1266119 (UMLS CUI [1,2])
C0018922 (UMLS CUI [1,3])
C1513749 (UMLS CUI [1,4])
C2945760 (UMLS CUI [1,5])
C0178648 (UMLS CUI [1,6])
C1417589 (UMLS CUI [1,7])
C1335877 (UMLS CUI [1,8])
C1266119 (UMLS CUI [2,1])
C3481430 (UMLS CUI [2,2])
C2700640 (UMLS CUI [2,3])
C0162768 (UMLS CUI [2,4])
C1414314 (UMLS CUI [2,5])
C1515032 (UMLS CUI [2,6])
C1417589 (UMLS CUI [2,7])
C1519594 (UMLS CUI [2,8])
C1335877 (UMLS CUI [2,9])
C0205245 (UMLS CUI [3,1])
C0039593 (UMLS CUI [3,2])
C0521091 (UMLS CUI [3,3])
C0439836 (UMLS CUI [3,4])
C1417589 (UMLS CUI [3,5])
C1336789 (UMLS CUI [3,6])
C0332286 (UMLS CUI [3,7])
C1533729 (UMLS CUI [3,8])
C0178648 (UMLS CUI [4,1])
C1511790 (UMLS CUI [4,2])
C4330825 (UMLS CUI [4,3])
C4525099 (UMLS CUI [4,4])
C0348026 (UMLS CUI [4,5])
C1880022 (UMLS CUI [4,6])
C1266119 (UMLS CUI [4,7])
C0205396 (UMLS CUI [5,1])
C2986472 (UMLS CUI [5,2])
C1515926 (UMLS CUI [5,3])
C1266119 (UMLS CUI [5,4])
C1527148 (UMLS CUI [5,5])
C2985566 (UMLS CUI [5,6])